Literature DB >> 27170275

Double C-H amination by consecutive SET oxidations.

Christopher J Evoniuk1, Sean P Hill, Kenneth Hanson, Igor V Alabugin.   

Abstract

A new method for intramolecular C-H oxidative amination is based on a FeCl3-mediated oxidative reaction of anilines with activated sp(3) C-H bonds. The amino group plays multiple roles in the reaction cascade: (1) as the activating group in single-electron-transfer (SET) oxidation process, (2) as a directing group in benzylic/allylic C-H activation at a remote position, and (3) internal nucleophile trapping reactive intermediates formed from the C-H activation steps. These multielectron oxidation reactions proceed with catalytic amounts of Fe(iii) and inexpensive reagents.

Entities:  

Year:  2016        PMID: 27170275     DOI: 10.1039/c6cc03106d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Expedient Synthesis of Indolo[2,3-b]quinolines, Chromeno[2,3-b]indoles, and 3-Alkenyl-oxindoles from 3,3'-Diindolylmethanes and Evaluation of Their Antibiotic Activity against Methicillin-Resistant Staphylococcus aureus.

Authors:  Chandrasekhar Challa; Jaice Ravindran; Mohini Mohan Konai; Sunil Varughese; Jubi Jacob; B S Dileep Kumar; Jayanta Haldar; Ravi S Lankalapalli
Journal:  ACS Omega       Date:  2017-08-30

2.  Oxidative Photocyclization of Aromatic Schiff Bases in Synthesis of Phenanthridines and Other Aza-PAHs.

Authors:  Martin Kos; Jaroslav Žádný; Jan Storch; Vladimír Církva; Petra Cuřínová; Jan Sýkora; Ivana Císařová; Febin Kuriakose; Igor V Alabugin
Journal:  Int J Mol Sci       Date:  2020-08-15       Impact factor: 5.923

3.  Testing the limits of radical-anionic CH-amination: a 10-million-fold decrease in basicity opens a new path to hydroxyisoindolines via a mixed C-N/C-O-forming cascade.

Authors:  Quintin Elliott; Gabriel Dos Passos Gomes; Christopher J Evoniuk; Igor V Alabugin
Journal:  Chem Sci       Date:  2020-02-21       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.